{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:32:20Z","timestamp":1782754340781,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The objective of this systematic review and meta-analysis was to assess the effectiveness of hyoscine n-butylbromide in labor progress.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The databases including PubMed, the Cochrane Library, Science-Direct, Scopus and Web of Science were searched for studies published up to December 2019. Articles that published as randomized controlled trials (RCTs), and full-text articles published in English or other languages were included and participants were primi or multigravida women who were in active phase of labor. The intervention included HBB compared to placebo (normal saline) that was used during active phase of labor. Pooled estimates were measured using the fixed or random effect model, while the overall effect was reported in a mean difference (MD). All data were analyzed using Review Manager 5.3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty studies involving 3108 women were included in meta-analysis. Based on subgroup analysis by parity, use of HBB significantly reduced the duration of the first stage of labor in primigravida women (MD\u2009=\u2009\u2212\u200957.73; 95% CI: [\u2212\u200961.48, \u2212\u200953.60]) and in multigravida women (MD\u2009=\u2009\u2212\u200990.74; 95% CI: [\u2212\u200997.24, \u2212\u200984.24]). Administering HBB could reduce the second stages of labor in primigravidas and multigravidas about 6\u2009min and 4\u2009min respectively. Also, HBB reduced the duration of the third stage of labor in multigravidas about 3\u2009min. APGAR score at one and 5 min after birth was not affected. The main maternal adverse effect was tachycardia and dry mouth. Labor duration in studies in which the participants were primi-and multigravida was not presented based on separate parities except for four papers, and the route of HBB administration was not the same across all studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although, the effect of HBB was minimal when multigravidas and primigravidas women were considered together, the HBB was clinically effective in primigravida and multigravida women for shortening the first and the second stages of labor. Also, HBB could reduce the length of the third stage of labor in multigravidas.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12884-020-2832-3","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T09:19:35Z","timestamp":1589361575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The effect of hyoscine n- butylbromide on labor progress: A systematic review"],"prefix":"10.1186","volume":"20","author":[{"given":"Zaynab","family":"Mohaghegh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6980-0693","authenticated-orcid":false,"given":"Parvin","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahla","family":"Faal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayesteh","family":"Jahanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alayna","family":"Surdock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foruzan","family":"Sharifipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zahedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"issue":"8","key":"2832_CR1","first-page":"CD009243","volume":"15","author":"AC Rohwer","year":"2012","unstructured":"Rohwer AC, Khondowe O, Young T. Antispasmodics for labour. Cochrane Database Syst Rev. 2012;15(8):CD009243.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10017","key":"2832_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0140-6736(15)00838-7","volume":"387","author":"L Alkema","year":"2016","unstructured":"Alkema L, Chou D, Hogan D, Zhang S, Moller A-B, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN maternal mortality estimation inter-agency group. Lancet. 2016;387(10017):462\u201374.","journal-title":"Lancet."},{"key":"2832_CR3","unstructured":"WHO. Maternal mortality 2018 [Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/maternal-mortality."},{"key":"2832_CR4","volume-title":"Obstetrics and the Newborn: An Illustrated Textbook. uk: Bailliere Tindall","author":"A Norman","year":"1997","unstructured":"Norman A, Eric V, Paul B. Obstetrics and the Newborn: An Illustrated Textbook. uk: Bailliere Tindall; 1997."},{"issue":"Suppl 1","key":"2832_CR5","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.ijgo.2004.01.011","volume":"85","author":"GJ Hofmeyr","year":"2004","unstructured":"Hofmeyr GJ. Obstructed labor: using better technologies to reduce mortality. Int J Gynaecol Obstet. 2004;85(Suppl 1):S62\u201372.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"2832_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1471-0528.2008.01962.x","volume":"116","author":"A Dencker","year":"2009","unstructured":"Dencker A, Berg M, Bergqvist L, Ladfors L, Thors\u00e9n L, Lilja H. Early versus delayed oxytocin augmentation in nulliparous women with prolonged labour\u2014a randomised controlled trial. BJOG. 2009;116(4):530\u20136.","journal-title":"BJOG."},{"key":"2832_CR7","first-page":"918","volume-title":"Normal Labor. Edition 24th Williams Obstetrics","author":"F Cunningham","year":"2014","unstructured":"Cunningham F, Leveno K, Bloom S, Spong C, Dashe J. Normal Labor. Edition 24th Williams Obstetrics; 2014. p. 918."},{"key":"2832_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.anireprosci.2004.05.010","volume":"82\u201383","author":"G Jenkin","year":"2004","unstructured":"Jenkin G, Young IR. Mechanisms responsible for parturition; the use of experimental models. Anim Reprod Sci. 2004;82\u201383:567\u201381.","journal-title":"Anim Reprod Sci"},{"issue":"7","key":"2832_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM199202133260705","volume":"326","author":"JA L\u00f3pez-Zeno","year":"1992","unstructured":"L\u00f3pez-Zeno JA, Peaceman AM, Adashek JA, Socol ML. A controlled trial of a program for the active management of labor. N Engl J Med. 1992;326(7):450\u20134.","journal-title":"N Engl J Med"},{"issue":"9","key":"2832_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3109\/14767058.2014.942628","volume":"28","author":"S Kirim","year":"2015","unstructured":"Kirim S, Asicioglu O, Yenigul N, Aydogan B, Bahat N, Bayrak M. Effect of intravenous hyoscine-N-butyl bromide on active phase of labor progress: a randomized double blind placebo controlled trial. J Matern Fetal Neonatal Med. 2015;28(9):1038\u201342.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"2832_CR11","first-page":"62","volume":"10","author":"VI Yuel","year":"2008","unstructured":"Yuel VI, Kaur V, Kaur D. Programmed labour for optimizing labor and delivery. JK Sci. 2008;10(2):62\u20134.","journal-title":"JK Sci"},{"issue":"5","key":"2832_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/0019-5359.40982","volume":"62","author":"P Aggarwal","year":"2008","unstructured":"Aggarwal P, Zutshi V, Batra S. Role of hyoscine N-butyl bromide (HBB, buscopan) as labor analgesic. Indian J Med Sci. 2008;62(5):179\u201384.","journal-title":"Indian J Med Sci"},{"issue":"2","key":"2832_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijgo.2013.08.013","volume":"124","author":"MI Ibrahim","year":"2014","unstructured":"Ibrahim MI, Alzeeniny HA, Ellaithy MI, Salama AH, Abdellatif MA. Drotaverine to improve progression of labor among nulliparous women. Int J Gynecol Obstet. 2014;124(2):112\u20137.","journal-title":"Int J Gynecol Obstet"},{"issue":"12","key":"2832_CR14","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1111\/j.1471-0528.2007.01497.x","volume":"114","author":"LA Samuels","year":"2007","unstructured":"Samuels LA, Christie L, Roberts-Gittens B, Fletcher H, Frederick J. The effect of hyoscine butylbromide on the first stage of labour in term pregnancies. BJOG. 2007;114(12):1542\u20136.","journal-title":"BJOG."},{"key":"2832_CR15","first-page":"485","volume":"4","author":"S Bashir","year":"2016","unstructured":"Bashir S, Mushtaq R. Effect of hyosine butylbromide on first stage of labour in term pregnancy. Pak Arm Forces Med J. 2016;4:485.","journal-title":"Pak Arm Forces Med J"},{"issue":"1","key":"2832_CR16","first-page":"1","volume":"2","author":"M Edessy","year":"2015","unstructured":"Edessy M, EL-Darwish A, Nasr A, Ali A, El-Katatny H, Tammam M. Different modalities in first stage enhancement of labor. Gen Health Med Sci. 2015;2(1):1\u20134.","journal-title":"Gen Health Med Sci"},{"issue":"6","key":"2832_CR17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.tjog.2017.10.003","volume":"56","author":"JO Imaralu","year":"2017","unstructured":"Imaralu JO, Kuti O, Badejoko OO, Loto OM, Olaleye A. Effect of hyoscine butyl-bromide on the duration of active phase of labor: A randomized-controlled trial. Taiwan J Obstet Gynecol. 2017;56(6):725\u201330.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"2832_CR18","first-page":"350","volume":"30","author":"MA Kandil","year":"2017","unstructured":"Kandil MA, Sayyed TM, El-Mallah EM, Rezk MA, Zidan HM. Hyoscine butylbromide for shortening of the first stage of labor in primigravid women. MMJ. 2017;30(2):350.","journal-title":"MMJ."},{"issue":"3","key":"2832_CR19","first-page":"0","volume":"1","author":"M Shirazi","year":"2016","unstructured":"Shirazi M, Shahbazi F, Akhavan S, Taskooh MS, Azadi F. Hyoscine-N-Butylbromide and Progression of Labor at Different Stages. Obstet Gynecol Cancer Res. 2016;1(3):0.","journal-title":"Obstet Gynecol Cancer Res"},{"issue":"4","key":"2832_CR20","first-page":"408","volume":"12","author":"L Sekhavat","year":"2012","unstructured":"Sekhavat L, Karbasi SA, Fallah R, Mirowliai M. Effect of hyoscine butylbromide first stage of labour in multiparus women. AJOL. 2012;12(4):408\u201311.","journal-title":"AJOL"},{"issue":"5","key":"2832_CR21","first-page":"59","volume":"13","author":"M Iravani","year":"2006","unstructured":"Iravani M, Bekhradi NH. Study of the effects of intravenous injection of Hyoscine on parturition (labor). JSSU. 2006;13(5):59\u201364.","journal-title":"JSSU."},{"issue":"3","key":"2832_CR22","first-page":"218","volume":"21","author":"Z Pahlavani-Sheikhi","year":"2017","unstructured":"Pahlavani-Sheikhi Z, Razavi M. Hyoscine-N-butylbromide effect on the acceleration of labor and postpartum hemorrhage in primigravida women. FEYZ. 2017;21(3):218\u201323.","journal-title":"FEYZ."},{"issue":"2","key":"2832_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3325\/cmj.2011.52.159","volume":"52","author":"S Makvandi","year":"2011","unstructured":"Makvandi S, Tadayon M, Abbaspour M. Effect of hyoscine-N-butyl bromide rectal suppository on labor progress in primigravid women: randomized doubleblind placebo-controlled clinical trial. Croat Med J. 2011;52(2):159\u201363.","journal-title":"Croat Med J"},{"issue":"12","key":"2832_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.4236\/ojog.2018.812111","volume":"8","author":"DD Barau","year":"2018","unstructured":"Barau DD, Agida ET, Onafowokan O, Adebayo FO. Effect of Hyoscine butyl bromide on the course of labour. OJOG. 2018;8(12):1102.","journal-title":"OJOG."},{"issue":"66","key":"2832_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.rmu.2015.01.001","volume":"17","author":"EM Trevi\u00f1o-Salinas","year":"2015","unstructured":"Trevi\u00f1o-Salinas EM. Castillo-Mart\u00edn del campo GE, Ayuzo-del Valle C, Guzm\u00e1n-L\u00f3pez A, Soria-L\u00f3pez JA, Iglesias-Benavides JL, et al. effect of hyoscine butylbromide on cervical dilation during labor. Medicina Universitaria. 2015;17(66):30\u20133.","journal-title":"Medicina Universitaria"},{"issue":"3","key":"2832_CR26","first-page":"103","volume":"22","author":"H Akleh","year":"2010","unstructured":"Akleh H, Al-Jufairi Z. Effect of Hyoscine-N-butyl bromide (Buscopan) in accelerating first stage of labor. J Bahrain Med Soc. 2010;22(3):103\u20137.","journal-title":"J Bahrain Med Soc"},{"key":"2832_CR27","volume-title":"The efficacy of intravenous hyoscine-n-butylbromide (buscopan\u00ae) for the acceleration of labour in first time parturients: a randomised, double-blind, placebo-controlled trial. Personal communication via email","author":"MA Mwaniki","year":"2011","unstructured":"Mwaniki MA. The efficacy of intravenous hyoscine-n-butylbromide (buscopan\u00ae) for the acceleration of labour in first time parturients: a randomised, double-blind, placebo-controlled trial. Personal communication via email; 2011."},{"issue":"8","key":"2832_CR28","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1471-0528.2008.01760.x","volume":"115","author":"R Raghavan","year":"2008","unstructured":"Raghavan R. The effect of hyoscine butyl bromide on the first stage of labour in term pregnancies. BJOG. 2008;115(8):1064.","journal-title":"BJOG"},{"key":"2832_CR29","first-page":"19","volume":"4","author":"G Accinelli","year":"1978","unstructured":"Accinelli G, Olivieri T, Vibelli C. The effectiveness of a new spasmolytic drug (DA 3177) during the active phase of labor. A double-blind clinical trial. Acta Ther. 1978;4:19\u201327.","journal-title":"Acta Ther"},{"issue":"3","key":"2832_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.15218\/zjms.2013.0047","volume":"17","author":"H Alani","year":"2013","unstructured":"Alani H, Salim RT. The effect of hyoscine N\u2013butyl bromide on the duration of active phase of labor. Zanco J Med Sci. 2013;17(3):549\u201355.","journal-title":"Zanco J Med Sci"},{"issue":"4","key":"2832_CR31","first-page":"70e3","volume":"3","author":"W Al-Khishali","year":"2012","unstructured":"Al-Khishali W, Rasheed F, Hussain S. The effect of 20 mg hyoscine butylbromide on Normal labor in Iraqi Primi-and multi-gravida women. J Adv Sci Res. 2012;3(4):70e3.","journal-title":"J Adv Sci Res"},{"issue":"1","key":"2832_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/TJOG.TJOG_57_18","volume":"36","author":"R Ibrahim","year":"2019","unstructured":"Ibrahim R, Nwobodo E, Tunau K, Burodo A, Sulaiman B, Garba J, et al. The effect of hyoscine butyl bromide in shortening the duration of first stage of labor: A single-blind randomized control study. Trop J Obstet Gynaecol. 2019;36(1):28\u201332.","journal-title":"Trop J Obstet Gynaecol"},{"issue":"90","key":"2832_CR33","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.14260\/Jemds\/2016\/1509","volume":"5","author":"SR Narappagari","year":"2016","unstructured":"Narappagari SR. Effect of hyoscine butylbromide (buscopan) as cervical spasmolytic agent in labour. JEMDS. 2016;5(90):6670\u20135.","journal-title":"JEMDS."},{"key":"2832_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/TCRM.S16415","volume":"7","author":"NH Al Qahtani","year":"2011","unstructured":"Al Qahtani NH, Al HF. The effect of hyoscine butylbromide in shortening the first stage of labor: A double blind, randomized, controlled, clinical trial. Ther Clin Risk Manag. 2011;7:495.","journal-title":"Ther Clin Risk Manag"},{"issue":"38","key":"2832_CR35","first-page":"57","volume":"19","author":"E Namaziyan","year":"2017","unstructured":"Namaziyan E, Mokhtari F. Use of hyoscine on labour process in nulliparous women. IJOGI. 2017;19(38):57\u201365.","journal-title":"IJOGI."},{"issue":"22","key":"2832_CR36","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1080\/14767058.2017.1359828","volume":"31","author":"AM Maged","year":"2018","unstructured":"Maged AM, Mosaad M, AbdelHak AM, Kotb MM, Salem MM. The effect of hyoscine butylbromide on the duration and progress of labor in primigravidae: a randomized controlled trial. J Matern Fetal Neonatal Med. 2018;31(22):2959\u201364.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"2832_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.15296\/ijwhr.2019.41","volume":"7","author":"M Ranjbaran","year":"2019","unstructured":"Ranjbaran M, Samani RO, Hafezi M, Mansori K, Mahdavi N, Tola HH. Hyoscine Butylbromide and the duration of labor: A systematic review and Meta-analysis study. IJWHR. 2019;7(3):239\u201345.","journal-title":"IJWHR."},{"key":"2832_CR38","first-page":"220","volume-title":"Country Guideline of Midwifery and Obstetric services","author":"FAM Torkestani","year":"2017","unstructured":"Torkestani FAM, Radpouyan L, Rahimi S, Hadipour L, Bakhshandeh M, et al. Country Guideline of Midwifery and Obstetric services. 3rd ed. Tehran: Charsouy Honar; 2017. p. 220.","edition":"3"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-2832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-020-2832-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-2832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T19:44:56Z","timestamp":1722887096000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-2832-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2832"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-2832-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"27 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Parvin Abedi and Shayesteh Jahanfar are both associate editors of BMC Pregnancy and Childbirth journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"291"}}